By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Antibe Therapeutics Inc. 

1063 King St. West
Suite 210
Hamilton  Ontario  L8S 4S3  Canada
Phone: 905-515-6132 Fax: 905-528-9862


SEARCH JOBS


Industry
Biotechnology






Company News
Antibe Therapeutics (ATE.V) Raises $968,500 In First Tranche Of Non-Brokered Private Placement 6/13/2016 11:15:24 AM
Antibe Therapeutics (ATE.V) Presenting Update On ATB-346 At International Hydrogen Sulfide Conference 5/31/2016 12:59:40 PM
Antibe Therapeutics (ATE.V) To Present At 2016 Bloom Burton & Co. Healthcare Investor Conference 5/2/2016 10:56:36 AM
Antibe Therapeutics (ATE.V) Announces The Launch Of PentOS OI Putty, A High-Quality Bone Graft Substitute For Oral And Maxillofacial Surgery 4/18/2016 10:56:28 AM
Antibe Therapeutics (ATE.V) Announces Appointment Of The Giordano Group, Inc, A Division Of Network 1 Financial Securities LLC, As US-BASED Investor Relations Consultant 4/1/2016 10:19:34 AM
Antibe Therapeutics (ATE.V) Announces Grant Of Stock Options 3/10/2016 11:01:24 AM
Antibe Therapeutics (ATE.V) Receives Approval To Proceed To Phase 2 Clinical Trial 3/7/2016 12:28:00 PM
Antibe Therapeutics (ATE.V)’ ATB-346 Receives Approval For Phase 2 Clinical Trial In Osteoarthritis Patients 3/7/2016 11:32:18 AM
Antibe Therapeutics (ATE.V) Reports Q3 2016 Interim Financial And Operating Results 3/1/2016 12:00:43 PM
Antibe Therapeutics (ATE.V) Release: Profound Preventative And Restorative Effects Of ATB-346 In Mice With Genetic Predisposition To Intestinal Cancer 2/25/2016 11:11:29 AM
123456
//-->